Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (431-440 of 662) with videos related to

Pageof 67
Sort By:
International Journal of Molecular Sciences|December 17, 2024
Somatic Recombination Between an Ancient and a Recent <i>NOTCH2</i> Gene Variant Is Associated with the NOTCH2 Gain-of-Function Phenotype in Chronic Lymphocytic LeukemiaRainer Hubmann, Martin Hilgarth, Tamara Löwenstern, et al.
Blood Advances|January 31, 2018
Variability of PD-L1 expression in mastocytosisEllen W Hatch, Mary Beth Geeze, Cheyenne Martin, et al.
Cancer Cell|January 18, 2005
Stat5 tetramer formation is associated with leukemogenesisRichard Moriggl, Veronika Sexl, Lukas Kenner, et al.
Current Allergy and Asthma Reports|February 17, 2026
Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil ActivationPeter Valent, Karin Hartmann, Gabriele Stefanzl, et al.
Oncotarget|January 14, 2017
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cellsRenate Wagner, Gerald Stübiger, Daniel Veigel, et al.
Wiener Klinische Wochenschrift|June 14, 2020
A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT studyAndreas L Petzer, Wolfgang R Sperr, Veronika Buxhofer-Ausch, et al.
Blood|November 19, 2016
CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosisGeorg Greiner, Nadine Witzeneder, Angelika Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilinKerstin Westritschnig, Birgit Linhart, Margarete Focke-Tejkl, et al.
Leukemia|April 7, 2019
Identification of a leukemia-initiating stem cell in human mast cell leukemiaGregor Eisenwort, Irina Sadovnik, Juliana Schwaab, et al.
Molecular Immunology|November 25, 2010
Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimerRaffaela Campana, Susanne Vrtala, Bernhard Maderegger, et al.
Pageof 67

Showing results (431-440 of 662) with videos related to

Sort By:
Pageof 67
International Journal of Molecular Sciences|December 17, 2024
Somatic Recombination Between an Ancient and a Recent <i>NOTCH2</i> Gene Variant Is Associated with the NOTCH2 Gain-of-Function Phenotype in Chronic Lymphocytic LeukemiaRainer Hubmann, Martin Hilgarth, Tamara Löwenstern, et al.
Blood Advances|January 31, 2018
Variability of PD-L1 expression in mastocytosisEllen W Hatch, Mary Beth Geeze, Cheyenne Martin, et al.
Cancer Cell|January 18, 2005
Stat5 tetramer formation is associated with leukemogenesisRichard Moriggl, Veronika Sexl, Lukas Kenner, et al.
Current Allergy and Asthma Reports|February 17, 2026
Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil ActivationPeter Valent, Karin Hartmann, Gabriele Stefanzl, et al.
Oncotarget|January 14, 2017
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cellsRenate Wagner, Gerald Stübiger, Daniel Veigel, et al.
Wiener Klinische Wochenschrift|June 14, 2020
A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT studyAndreas L Petzer, Wolfgang R Sperr, Veronika Buxhofer-Ausch, et al.
Blood|November 19, 2016
CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosisGeorg Greiner, Nadine Witzeneder, Angelika Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilinKerstin Westritschnig, Birgit Linhart, Margarete Focke-Tejkl, et al.
Leukemia|April 7, 2019
Identification of a leukemia-initiating stem cell in human mast cell leukemiaGregor Eisenwort, Irina Sadovnik, Juliana Schwaab, et al.
Molecular Immunology|November 25, 2010
Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimerRaffaela Campana, Susanne Vrtala, Bernhard Maderegger, et al.
Pageof 67